Single-center experience of extracorporeal membrane oxygenation mainly anticoagulated with nafamostat mesilate

BACKGROUND: Bleeding remains the chief concern during extracorporeal membrane oxygenation (ECMO). Recently, several studies proposed nafamostat mesilate (NM) as an alternative anticoagulant to heparin due to reduced bleeding complications and comparable thromboembolic episodes. The aim of this study...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Thorac Dis
Egile Nagusiak: Han, Woosik, San Bok, Jin, Cho, Hyun Jin, Yu, Jae Hyeon, Na, Myung Hoon, Kang, Shinkwang, Kang, Min-Woong
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: AME Publishing Company 2019
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6687983/
https://ncbi.nlm.nih.gov/pubmed/31463115
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2019.06.30
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak